SOLENO THERAPEUTICS INC Quarterly Comprehensive Income (Loss), Net of Tax, Attributable to Parent in USD from Q1 2021 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.
Summary
Soleno Therapeutics Inc quarterly Comprehensive Income (Loss), Net of Tax, Attributable to Parent history and growth rate from Q1 2021 to Q2 2024.
  • Soleno Therapeutics Inc Comprehensive Income (Loss), Net of Tax, Attributable to Parent for the quarter ending June 30, 2024 was -$21.9M, a 158% decline year-over-year.
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, Quarterly (USD)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$21.9M -$13.4M -158% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 -$21.5M -$13.2M -158% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q3 2023 -$10.9M -$4.73M -77.1% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-08
Q2 2023 -$8.49M -$1.77M -26.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 -$8.34M -$2.61M -45.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q3 2022 -$6.13M +$2.01M +24.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 -$6.72M +$4.26M +38.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 -$5.73M +$3.23M +36.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q3 2021 -$8.14M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$11M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 -$8.95M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.